ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "depression"

  • Abstract Number: 1598 • ACR Convergence 2020

    Efficacy of Universal Depression Screening in a Rheumatology Clinic

    Osman Bhatty1 and Michael Lucke1, 1Allegheny Health Network, Pittsburgh, PA

    Background/Purpose: Depression has long been viewed as a comorbid condition in rheumatic diseases. Population studies have confirmed an increased incidence in patients with rheumatoid arthritis,…
  • Abstract Number: 0194 • ACR Convergence 2020

    Depression Symptoms but Not Clinically Diagnosed Depression Predict Mortality in Rheumatoid Arthritis

    Jose Felix Restrepo1, Inmaculada Del Rincon1 and Agustin Escalante1, 1University of Texas Health Science Center at San Antonio/ Department of Medicine/ Rheumatology, San Antonio, TX

    Background/Purpose: Depression and depressive symptoms are common but under-recognized in rheumatoid arthritis (RA). Few studies have examined depression symptoms in RA patients compared to clinically…
  • Abstract Number: 1733 • ACR Convergence 2020

    Patients with Rheumatoid Arthritis and Comorbid Depression Have High Levels of RAPID3 (Routine Assessment of Patient Index Data) and FAST3 (Fibromyalgia Assessment Screening Index) on a Multidimensional Health Assessment Questionnaire (MDHAQ)

    Rosa Morlà1, Tengfei Li2, Jose Inciarte-Mundo3, Isabel Castrejon Fernandez4, Jose Gómez-Puerta5, Raimon Sanmartí5 and Theodore Pincus6, 1Hospital Universitari Clínic de Barcelona, Barcelona, Spain, 2Georgetown University, Washigton, 3Hospital Universitari Clínic de Barcelona, Barcelona, 4Hospital General Universitario Gregorio Marañón, Chicago, IL, 5Hospital Universitari Clínic de Barcelona, Barcelona, Catalonia, Spain, 6Rush University Medical Center, Chicago, IL

    Background/Purpose: Patients with rheumatoid arthritis (RA) have higher comorbid depression and/or fibromyalgia (FM) than the general population. A multidimensional health-assessment questionnaire (MDHAQ) includes two queries…
  • Abstract Number: 0336 • ACR Convergence 2020

    Anxiety and Depression in Psoriatic Arthritis (PsA) – Prevalence and Impact on Patient Reported Outcomes: Real-World Survey in the US and Europe

    Laure Gossec1, Jessica Walsh2, Kaleb Michaud3, Elizabeth Holdsworth4, Steven Peterson5, Sophie Meakin4, Nicola Booth4, Soumya Chakravarty6, James Piercy4 and Alexis Ogdie7, 1Sorbonne Université and Hôpital Universitaire Pitié Salpêtrière, Paris, France, 2University of Utah School of Medicine, George E. Wahlen Veteran Affairs Medical Center, Salt Lake City, UT, 3University of Nebraska Medical Center, Omaha, NE, 4Adelphi Real World, Bollington, United Kingdom, 5Janssen Immunology Global Commercial Strategy Organization, Horsham, PA, 6Janssen Scientific Affairs, LLC, Horsham, PA, USA and Drexel University College of Medicine, Horsham, PA, 7Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Anxiety and depression are comorbidities among PsA patients. The impact of anxiety and depression on outcomes in PsA patients has not been characterized in…
  • Abstract Number: 1737 • ACR Convergence 2020

    What Influences Fatigue Improvement in Rheumatoid Arthritis? A Prospective Cohort Study

    Samar Aboulenain1, Elie Donath1 and Ozlem Pala2, 1University of Miami Miller School, West Palm Beach, FL, 2University of Miami Miller School, Fort Lauderdale, FL

    Background/Purpose: Fatigue is a common and debilitating complication in patients with rheumatoid arthritis (RA). Its mechanism is not fully elucidated, and when persistent is often…
  • Abstract Number: 0434 • ACR Convergence 2020

    Changes in Mental Health During the COVID-19 Pandemic Among Individuals with Rheumatic Disease

    Patricia Katz1, Sofia Pedro2, Kristin Wipfler3, Teresa Simon4, Yomei Shaw5, Adam Cornish6 and Kaleb Michaud7, 1University of California, San Francisco, Novato, CA, 2FORWARD-The National Data Bank for Rheumatic Diseases, Wichita, 3FORWARD, The National Databank for Rheumatic Diseases, Omaha, NE, 4Bristol-Myers Squibb Company (at time of analysis), Princeton, NJ, 5Forward, The National Databank for Rheumatic Diseases, East Lansing, MI, 6FORWARD, 68134, NE, 7University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Symptoms of both depression and anxiety are often elevated among individuals with rheumatic conditions, and stress levels may play a role in each.  Depression,…
  • Abstract Number: 1804 • ACR Convergence 2020

    Impact of the Kynurenine/Tryptophan Pathway on Cognitive Dysfunction and Depression in Systemic Lupus Erythematosus

    Erik Anderson1, Joanna Fishbein2, Joseph Hong2, Julien Roeser3, Richard Furie4, Cynthia Aranow2, Bruce Volpe2, Betty Diamond5 and Meggan Mackay6, 1Feinstein Institutes for Medical Research, New York, NY, 2Feinstein Institutes for Medical Research, Manhasset, NY, 3Charles River Laboratories, South San Francisco, CA, 4Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY, 5Northwell Health, Manhasset, NY, 6Feinstein Institute for Medical Research, Manhasset, NY

    Background/Purpose: Tryptophan (TRP) is metabolized to kynurenine (KYN), quinolonic acid [QA, a N-methyl D-aspartate receptor (NMDAR) agonist] and kynurenic acid (KA, an NMDAR antagonist). KYN/TRP…
  • Abstract Number: 006 • 2020 Pediatric Rheumatology Symposium

    Increasing Rates of Standardized Depression Screening in Youth with Systemic Lupus Erythematosus in a Pediatric Rheumatology Clinic

    Victoria Newsome 1, Jodi Dingle 2, Manda Mitchell 3, Thomas Brent Graham 4 and Alaina Davis5, 1Nashville, 2Vanderbilt University Medical Center, Nashville, Tennessee, 3Nashville, Tennessee, 4Vanderbilt University Medical Center, Nashville, 5Monroe Carell Jr. Children’s Hospital at Vanderbilt, Nashville, Tennessee

    Background/Purpose: Depression is common among youth with SLE.  Early identification and treatment of depression has the potential to improve health outcomes for youth with SLE.…
  • Abstract Number: 049 • 2020 Pediatric Rheumatology Symposium

    Levels of Anxiety and Depressive Symptoms in Juvenile Idiopathic Arthritis (JIA) and Their Correlation to Disease Manifestations Using Patient-Reported Outcomes Measurement Information System (PROMIS®) Measures

    Danielle Fair1, Judyann Olson 2, Jan Lemke 3, Stella Protopapas 4, Ke Yan 5 and Jian Zhang 6, 1Medical College of Wisconsin & Affiliated Hospitals: Children's Wisconsin, Wauwatosa, Wisconsin, 2Medical College of Wisconsin: Children's Wisconsin, Wauwatosa, Wisconsin, 3Children's Wisconsin, Milwaukee, Wisconsin, 4Riley Children’s Hospital at Indiana University, Indianapolis, Indiana, 5Medical College of Wisconsin, Milwaukee, Wisconsin, 6Medical College of Wisconsin, 53226, Wisconsin

    Background/Purpose: Children with chronic diseases have higher rates of mental health issues and less favorable outcomes than the general pediatric population.  Children with JIA experience…
  • Abstract Number: 134 • 2020 Pediatric Rheumatology Symposium

    Evaluation of Self-report Screening Measures in the Detection of Depressive and Anxiety Disorders Among Children and Adolescents with Systemic Lupus Erythematosus

    Michelle Quilter1, Katherine Cost 2, Reva Schachter 3, Julie Couture 4, Ashley Danguecan 5, Lawrence Ng 6, Daniela Dominguez 6, Linda Hiraki 7, Deborah Levy 8, Earl D. Silverman 9, Kate Neufeld 10, Andrea Knight 11 and Daphne Korczak 2, 1Dept. of Psychiatry, Hospital for Sick Children, Dept. of Psychiatry, University of Toronto, Toronto, Ontario, Canada, 2Dept. of Psychiatry, Hospital for Sick Children, Dept. of Psychiatry, University of Toronto, Toronto, Canada, 3Dept. of Psychiatry, Hospital for Sick Children,, Toronto, Canada, 4Division of Pediatric Rheumatology-Immunology, CHU Sainte-Justine, Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada, 5Hospital for Sick Children, Toronto, Canada, 6Division of Rheumatology, The Hospital for Sick Children, Toronto, Canada, 7Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, Canada, 8Division of Rheumatology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Canada, 9Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Translational Medicine, Research Institute, The Hospital for Sick Children, Toronto, Canada, 10University of Toronto, The Hospital for Sick Children, Toronto, Canada, 11SickKids Research Institute, Toronto, Canada

    Background/Purpose: Screening for co-morbid psychiatric disorder is of high clinical importance in childhood-onset systemic lupus erythematosus (cSLE). However, there are no validated screening measures for…
  • Abstract Number: 1341 • 2019 ACR/ARP Annual Meeting

    Impact of Tocilizumab on Anxiety and Depression in Patients with Rheumatoid Arthritis

    Shmuel Tiosano 1, Yarden Yavne 1, Abdulla Watad 2, Pnina Langevitz 3, Merav Lidar 4, Joy Feld 5, Moshe Tishler 6, Suhail Aamar 7, Ori Elkayam 8, Alexandra Balbir-Gurman 9, Yair Molad 10, Sharon Ehrlich 11, Daniela Amital 12 and Howard AMITAL1, 1Department of Medicine B, Ramat-Gan, Israel, 2Department of Medicine “B”, Zabludowicz Center for Autoimmune Diseases Sheba Medical Center, Ramat-Gan, Israel, 3Rhematology Unit, Ramat-Gan, Israel, 4Rheumatology Unit Sheba Medical Center, Ramat Gan, Israel, 5Carmel Hospital, Haifa, Israel, 65Internal Department B, Assaf Harofeh Medical Center, Zrifin, Israel, Zrifin, Israel, 7Rheumatology Unit, Hadassah Mount Scopus Medical Center, Jeursalem, Israel, Jerusalem, Israel, 8Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 9Rambam Medical Center, Haifa, Israel, 10Rabin Medical Center, Beilinson Hospital, and Tel Aviv University, Petach Tikva, HaMerkaz, Israel, 11Roche Pharmaceuticals (Israel) Ltd., Hod HaSharon, Israel., Hod-Hashaon, Israel, 12Ness Ziona Beer-Yaacov Mental Health Center,, Beer-Yaakov, Israel

    Background/Purpose: Mood disorders, such as anxiety and depression are extremely prevalent amongst patients with rheumatoid arthritis (RA). In this study we sought to assess the…
  • Abstract Number: 1414 • 2019 ACR/ARP Annual Meeting

    Improvement of Mental Health and Quality of Life During Therapy with Tocilizumab

    Frank Behrens1, Werner A Biewer 2, Gerd Burmester 3, Martin Feuchtenberger 4, Michael W. Hofmann 5, Peter Kästner 6, Herbert Kellner 7, Ramona König 8, Anke Liebhaber 9, Christina Luig 10, Regina Max 11, Patrizia Sternad 12, Hans-Peter Tony 13 and Christopher Amberger 14, 1Rheumatology Goethe-University Frankfurt & Fraunhofer IME-TMP, Frankfurt, Germany, 2Rheumatologische Schwerpunktpraxis Saarbrücken, Saarbrücken, Germany, 3Charité—University Medicine Berlin, Berlin, Germany, 4Rheumatologie/Klinische Immunologie, Kreiskliniken Altötting-Burghausen, Burghausen, Germany, 5Chugai Pharma Europe Ltd., Frankfurt/Main, Germany, 6MVZ Ambulantes Rheumazentrum Erfurt, Erfurt, Germany, 7Praxis Prof. Herbert Kellner, Munich, Germany, 8Justus-Liebig-Universität Giessen and Kerckhoff-Klinik-Forschungs-GmbH, Giessen, Germany, 9Internistisch-Rheumatologische Arztpraxis, Halle, Halle, Germany, 10Roche Pharma AG, Rheumatologie, Grenzach-Wyhlen, Germany, 11Universitätsklinikum Heidelberg, Heidelberg, Germany, 12Gemeinschaftspraxis, Planegg, Planegg, Germany, 13Department of Rheumatology/Clinical Immunology, University Hospital, Wuerzburg, Germany, Würzburg, Germany, 14Rheumatologische Gemeinschaftspraxis Dr. Pick/Dr. Amberger, Bad Neuenahr, Germany

    Background/Purpose: In rheumatoid arthritis (RA), the proinflammatory cytokine IL-6 is associated with mental disorders such as depression and anxiety.1 Furthermore, depression and anxiety are comorbidities…
  • Abstract Number: 1444 • 2019 ACR/ARP Annual Meeting

    Tofacitinib in Patients with Rheumatoid Arthritis and Indicative of Depression And/or Anxiety: A Post Hoc Analysis of Phase 3 and Phase 3b/4 Clinical Trials

    Gustavo Citera1, Rakesh Jain 2, Fedra Irazoque 3, Renato Guzman 4, Hugo Madariaga 5, David Gruben 6, Lisy Wang 6, Lori Stockert 7, Ming-Ann Hsu 8, Karina Santana 9, Abbas Ebrahim 10 and Dario Ponce de Leon 11, 1Instituto de Rehabilitación Psicofísica, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 2Texas Tech University School of Medicine, Lubbock, TX, 3Hospital Angeles Mocel, San Miguel, Mexico, 4Fundación Universitaria Juan N. Corpas e IDEARG, Bogota, Colombia, 5Clínica del Sur, Arequipa, Peru, 6Pfizer Inc, Groton, CT, 7Pfizer Inc, Collegeville, PA, 8Pfizer Inc, Groton, 9Pfizer Inc, Mexico City, Mexico, 10Pfizer Inc, Collegeville, 11Pfizer Inc, Lima, Peru

    Background/Purpose: Depression and anxiety are common in patients (pts) with RA1 and can lead to reduced quality of life, functional capacity, and RA treatment response.2-4…
  • Abstract Number: 1490 • 2019 ACR/ARP Annual Meeting

    Blockage of TNFα and IL-12/23 Improves Depressive Symptoms in Patients with Psoriatic Arthritis – Analysis of Clinical Trial Data

    Lihi Eder1, Alexis Ogdie 2 and Yujie Zhong 3, 1Women’s College Hospital and the Department of Medicine, University of Toronto, Toronto, Canada, 2Department of Medicine and Rheumatology and Department of Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 3School of Statistics and Management, Shanghai University of Finance and Economics, Cambridge, China (People's Republic)

    Background/Purpose: The prevalence of depression is increased in patients with psoriatic arthritis (PsA). Little is known about the impact of effective control of inflammation on…
  • Abstract Number: 2822 • 2019 ACR/ARP Annual Meeting

    Depression and Subsequent Risk for Incident Seronegative Rheumatoid Arthritis Among Women

    Jeffrey Sparks1, Susan Malspeis 1, Jill Hahn 2, Andrea Roberts 2, Laura Kubzansky 2 and Karen Costenbader 1, 1Brigham and Women's Hospital, Boston, MA, 2Harvard School of Public Health, Boston, MA

    Background/Purpose: Depression is associated with elevated systemic inflammation and risk of several chronic diseases including lupus, psoriasis, and inflammatory bowel disease. However, the association between…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 15
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology